04/22/2024
3:34 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2024
3:35 PM | Fairey William (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:37 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
3:50 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:38 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
3:35 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13G | |
02/22/2024
12:22 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
|
02/21/2024
8:51 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:41 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:44 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:46 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
8:48 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:49 PM | KalVista Pharmaceuticals (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13D/A | |
02/16/2024
3:32 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:21 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:52 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
4:13 PM | KalVista Pharmaceuticals (Filer)
| Form 424B5 | |
02/13/2024
8:11 AM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:20 AM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:23 AM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:06 AM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:08 AM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:55 AM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
7:30 PM | KalVista Pharmaceuticals (Subject)
Saturn V Capital Management LP (Filed by)
| Form SC 13G | |
02/09/2024
8:16 AM | KalVista Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
7:11 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:38 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
6:07 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
7:24 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:02 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:04 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:26 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
7:57 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
5:05 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:24 PM | KalVista Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/08/2024
3:47 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:13 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:44 PM | KalVista Pharmaceuticals (Issuer)
Koh Bong Y (Reporting)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:16 PM | KalVista Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023
4:12 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Americans Now Need $1.46M to Retire… (Ad) Americans now say they need $1.46M in order to “retire comfortably.”
For many, retiring in your 60s may be out of the picture altogether…
But luckily for you – a limited window in today’s crypto market could help you retire quickly in wealth AND comfort! Click here to access the free Crypto Retirement Blueprint now. |
12/14/2023
12:33 PM | Frazier Life Sciences Public Fund, L.P. (Filed by)
KalVista Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/28/2023
3:52 PM | Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
3:53 PM | KalVista Pharmaceuticals (Issuer)
Pereira Brian JG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
3:54 PM | KalVista Pharmaceuticals (Issuer)
Unkart Edward W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
3:54 PM | KalVista Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2023
3:55 PM | KalVista Pharmaceuticals (Issuer)
Treanor Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2023
3:29 PM | Cha Albert (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
5:05 PM | Cha Albert (Reporting)
KalVista Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/07/2023
3:35 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:18 PM | KalVista Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/21/2023
7:05 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:05 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:06 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:07 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
7:09 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:30 PM | KalVista Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2023
8:37 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023
8:39 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4/A | |
05/22/2023
8:40 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4/A | |
05/22/2023
8:33 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
8:35 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/22/2023
8:36 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4/A | |
05/19/2023
8:18 PM | Feener Edward P. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:19 PM | KalVista Pharmaceuticals (Issuer)
Palleiko Benjamin L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:20 PM | KalVista Pharmaceuticals (Issuer)
Yea Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:16 PM | Audhya Paul K. (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
8:17 PM | Crockett Thomas Andrew (Reporting)
KalVista Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
